Archive:
Aug 11, 2023, 12:00 AM
CNYBAC Client Zetagen Therapeutics Secures 9.79 Million USD Series B Funding Raise for Advancement of ZetaMet™ and ZetaMAST™ for Treatment of Metastatic Bone and Soft Tissue Lesions
August
11,
2023
Press Release Provided By Joe Loy, CEO, Zetagen
Zetagen Therapeutics Secures 9.
Read More »